The shareholders of cardiovascular technology firm ATS Medical (NASDAQ: ATSI) voted in favor of the company’s $370 million sale to neighboring device giant Medtronic Inc. (NYSE: MDT). About 79 percent of the company’s outstanding shares were voted, with about 95 percent of those in approval of the $4-per-share deal, according to a statement from Plymouth, […]
Cardiology device maker ATS Medical Inc. (Nasdaq: ATSI) reported the first commercial implant in China of its stentless heart valve. The procedure marks an important milestone for ATS as the company tries to strengthen its position in China, which has the potential to be the largest valve replacement market in the world within the next […]
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.